Current lentiviral vector systems (the third generation ... “Since lentiviral vectors can stably integrate into target cells, the approach could enhance treatment prospects in younger patients ...

As the particles are often pseudotyped with the envelope of the vesicular stomatitis virus (VSV), the vector can serve to introduce genes into a broad range of tissues and can be used in vivo.

The popularity of viral vector-based gene therapies and vaccines is rapidly growing ... Download this application note from Thermo Fisher Scientific to learn how scientists have used their lentiviral ...

may provide the first realistic test of a targeted neuroprotective strategy for patients with PD. Kordower, J.H. et al. Neurodegeneration prevented by lentiviral vector delivery of GDNF in primate ...

Vyriad's targeted lentiviral vector platform provides T-cell specificity and activation in vivo, enabling delivery of CAR payloads to T cells in their natural environment. Through its viral vector ...